TIGAR and cancer: PFKFB4 shows predominantly bisphosphatase activity, leading to the suggestion that these cancer cells rely on PFKFB4 to dampen glycolytic flux, promote the PPP and manage ROS accumulation - very similar to the proposed action of TIGAR.